Tag: dose-dense

Dose-dense temozolomide does not improve survival in newly diagnosed glioblastoma

byAndrew Bishara

October 13, 2013

Image: PD 1. Dose-dense (DD) Temozolomide does not improve overall survival or progression-free survival in newly diagnosed glioblastoma. 2. O6methylguanine-DNA ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
An absence of cardiovascular risk factors is linked to over ten additional healthy years
Association between serum albumin to creatinine ratio and non-alcoholic fatty liver disease: a longitudinal cohort study in non-obese Chinese individuals

No Result

View All Result